Loading clinical trials...
Loading clinical trials...
Cardiac resynchronization therapy reduces mortality in patients with systolic heart failure and left bundle branch block. Reduced biventricular pacing can lead to therapy failure. Most effective mortality reduction was seen with a BiV pacing above 98%. Reduced BiV pacing is a common phenomenon with potential impact on CRT-response and pts' prognosis. Frequent ventricular ectopy may be associated with attenuated benefit from CRT. The investigators sought to systematically assess the effect of ventricular arrhythmia treatment on BiV pacing.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
University Hospital Cologne
Cologne, North Rhine-Westphalia, Germany
Start Date
September 1, 2020
Primary Completion Date
August 1, 2021
Completion Date
August 1, 2021
Last Updated
November 15, 2021
65
ACTUAL participants
Catheter ablation of ventricular arrhythmia
PROCEDURE
Intensified medical therapy
DRUG
Lead Sponsor
Universitätsklinikum Köln
NCT06743789
NCT07263139
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06255457